Bioactivation of toxicants by cytochrome P450-mediated dehydrogenation mechanisms

Advances in Experimental Medicine and Biology

Volumn 500, Issue , 2001, Pages 53-62

  Yost, Garold S ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CRESOL; CYTOCHROME P450; FURAFYLLINE; LAURIC ACID; N METHYLFORMAMIDE; PARACETAMOL; SKATOLE; URETHAN; VALPROIC ACID; XANTHINE;

CHEMICAL STRUCTURE; CONFERENCE PAPER; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER TOXICITY; LUNG PARENCHYMA; NONHUMAN; OXIDATION; OXYGENATION; PRIORITY JOURNAL; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 0035703728     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0667-6_6     Document Type: Conference Paper

References (24)

1. Expression and localization of CYP3A4 and CYP3A5 in human lung
2. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes
3. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides
4. 1
5. Cytochrome P450-dependent desaturation of lauric acid: Isoform selectivity and mechanism of formation of 11-dodecenoic acid
6. 6-ethenoadenosine
7. Chemical synthesis and cytotoxic properties of N-alkylcarbamic acid thioesters, metabolites of hepatotoxic formamides
8. Evaluation of cytochrome P450 mechanism and kinetics using kinetic deuterium isotope effects
9. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by CYP2FI expressed in human lymphoblastoid cells
10. Alkylation of 2′-deoxynucleosides and DNA by quinone methides derived from 2,6-di-tert-butyl-4-methylphenol
11. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues
12. Identification of a new P-450 expressed in human lung: Complete cDNA sequence, cDNA-directed expression and chromosome mapping
13. The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping
14. Metabolic activation of toxins: Tissue-specific expression and metabolism in target organs
15. Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: Detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate
16. Formation and detection of 3-methylindole DNA adducts
17. CYP4 isozyme specificity and the relationship between ω-hydroxylation and terminal desaturation of valproic acid
18. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole
19. Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole
20. Evidence supporting the formation of 2, 3-epoxy-3-methylindoline: A reactive intermediate of the pneumotoxin 3-methylindole
21. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: Correlation of 3-methyleneindolenine formation and protein-binding
22. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene
23. Selected, nontherapeutic agents